Voyager Therapeutics inks deal with Novartis 08-Mar-2022 By Jane Byrne Voyager Therapeutics Inc has secured a license option agreement valued at potentially more than US$1.7bn with Swiss pharma group, Novartis.
Roche deal latest in AAV gene therapy partnership plan for Dyno 19-Oct-2020 By Jane Byrne US company, Dyno Therapeutics, has inked a deal with Roche to develop next-generation AAV gene therapy vectors for central nervous system (CNS) diseases and liver-directed therapies.
